These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2619972)

  • 21. Depression: advances in drug treatment.
    Hopkins S
    Nurs Stand; 1993 Nov 24-30; 8(10):36. PubMed ID: 8297750
    [No Abstract]   [Full Text] [Related]  

  • 22. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part I: monoamine oxidase inhibitors.
    López-Muñoz F; Alamo C; Juckel G; Assion HJ
    J Clin Psychopharmacol; 2007 Dec; 27(6):555-9. PubMed ID: 18004120
    [No Abstract]   [Full Text] [Related]  

  • 24. Psychodynamic aspects in the use of monoamine oxidase inhibitor antidepressants.
    Roskos SR; Takahashi T
    Bull Menninger Clin; 1981 Mar; 45(2):143-8. PubMed ID: 7260455
    [No Abstract]   [Full Text] [Related]  

  • 25. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():430A-431A. PubMed ID: 1498903
    [No Abstract]   [Full Text] [Related]  

  • 26. Monoamine oxidase inhibitors.
    Lippmann S
    Am Fam Physician; 1986 Jul; 34(1):113-9. PubMed ID: 3728254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The treatment of depression: update 1984.
    Enowitch BI
    Conn Med; 1984 Nov; 48(11):703-6. PubMed ID: 6391806
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies of selective and reversible monoamine oxidase inhibitors.
    Mann JJ; Aarons SF; Frances AJ; Brown RD
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):62-6. PubMed ID: 6429130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical depression: is there a need for a better definition.
    Hardy JL
    Psychiatr J Univ Ott; 1989 Jun; 14(2):352-3. PubMed ID: 2668987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tyramine and new monoamine oxidase inhibitor drugs.
    Simpson GM; de Leon J
    Br J Psychiatry Suppl; 1989 Oct; (6):32-7. PubMed ID: 2695125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tranylcypromine treatment of major depression.
    Liebowitz MR
    J Clin Psychiatry; 1987 Jul; 48(7):303. PubMed ID: 3597337
    [No Abstract]   [Full Text] [Related]  

  • 32. Guidelines for the pharmacological management of depression.
    Creelman W; Goethe JW
    Conn Med; 1985 Sep; 49(9):565-9. PubMed ID: 4042649
    [No Abstract]   [Full Text] [Related]  

  • 33. Phenelzine as a possible treatment for depression in schizophrenic patients.
    Melamed Y; Karniel E; Szor H
    Isr J Psychiatry Relat Sci; 1996; 33(3):211-2. PubMed ID: 9009521
    [No Abstract]   [Full Text] [Related]  

  • 34. Coadministration of phenelzine and methylphenidate for treatment-resistant depression.
    Shelton Clauson A; Elliott ES; Watson BD; Treacy J
    Ann Pharmacother; 2004 Mar; 38(3):508. PubMed ID: 14970373
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical and laboratory studies with selective monoamine-oxidase-inhibiting drugs. Implications for hypothesized neurotransmitter changes associated with depression and antidepressant drug effects.
    Murphy DL; Cohen RM; Siever LJ; Roy B; Karoum F; Wyatt RJ; Garrick NA; Linnoila M
    Mod Probl Pharmacopsychiatry; 1983; 19():287-303. PubMed ID: 6408411
    [No Abstract]   [Full Text] [Related]  

  • 36. Atypical depression. A valid clinical entity?
    Stewart JW; McGrath PJ; Rabkin JG; Quitkin FM
    Psychiatr Clin North Am; 1993 Sep; 16(3):479-95. PubMed ID: 8415233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antidepressive action, pharmacokinetic characteristics and biochemical properties of cimoxatone, a new reversible MAO-A inhibitor].
    Poirier MF; Olié JP; Lôo H; Deniker P; Strolin Benedetti M; Rovei V; Lesage A
    Encephale; 1983; 9(4):331-43. PubMed ID: 6368197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MAO inhibitors. new biochemical and clinical findings.
    Psychopharmacol Bull; 1981 Jul; 17(3):154-61. PubMed ID: 7291464
    [No Abstract]   [Full Text] [Related]  

  • 39. Depression in medical illness. Workshop report.
    Paykel E
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):205-7. PubMed ID: 8468445
    [No Abstract]   [Full Text] [Related]  

  • 40. [Current biological therapies of depression].
    Loo H
    Rev Med Brux; 1983 Apr; 4(4):235-8. PubMed ID: 6878924
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.